Price $296.27 |
Market Cap
17.67B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
34.1
|
P/B
76.29
|
P/S
7.49
|
Dividend %
-
|
|
P/CF
176.7
|
P/FCF
28.7
|
Op. Cash Flow
790.5K
|
FCF
9.9
|
|
Op. Margin
27.30%
|
Net Margin
22.10%
|
ROE
-615.10%
|
ROI
35.00%
|
|
ROA
19.30%
|
EPS Growth
-5.10%
|
Current Ratio
1.7
|
Debt/Equity
519.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Eyenovia Inc (EYEN) | $5.31 | - | - | 127.6M | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $1.23 | - | - | 113.1M | Strong Buy |
| IRIDEX Corporation (IRIX) | $7.07 | - | - | 104.8M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.11 | - | - | 12.5B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $6.71 | - | - | 217.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
